Evidence map›Paper›PMID 39417379›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Individualized, cross-validated prediction of future dementia using cognitive assessments in people with mild cognitive symptoms.

Emma Borland, Niklas Mattson-Carlgren, Pontus Tideman, Alzheimer's Disease Neuroimaging Initiative, Erik Stomrud, Oskar Hansson, Sebastian Palmqvist

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emma BorlandClinical Memory Research Unit, Department of Clinical Sciences, Malmö, Faculty of Medicine at Lund University, Clinical Research Centre, Malmö, Sweden.
Niklas Mattson-CarlgrenClinical Memory Research Unit, Department of Clinical Sciences, Malmö, Faculty of Medicine at Lund University, Clinical Research Centre, Malmö, Sweden.
Pontus TidemanClinical Memory Research Unit, Department of Clinical Sciences, Malmö, Faculty of Medicine at Lund University, Clinical Research Centre, Malmö, Sweden.
Alzheimer's Disease Neuroimaging Initiative
Erik StomrudClinical Memory Research Unit, Department of Clinical Sciences, Malmö, Faculty of Medicine at Lund University, Clinical Research Centre, Malmö, Sweden.
Oskar HanssonClinical Memory Research Unit, Department of Clinical Sciences, Malmö, Faculty of Medicine at Lund University, Clinical Research Centre, Malmö, Sweden.
Sebastian PalmqvistClinical Memory Research Unit, Department of Clinical Sciences, Malmö, Faculty of Medicine at Lund University, Clinical Research Centre, Malmö, Sweden.

Funding

Prospective validation and implementation of high-performing blood biomarkers and digital cognitive tests for detection of Alzheimer's disease in specialist memory clinic and primary care settingsR01AG083740 · NIA · LUNDS UNIVERSITET · PI Sebastian Palmqvist · 2023 to 2026
$1.9M
ALF agreement 2022-Projekt0080ALF agreement 2022-Projekt0107Alzheimer's AssociationEU Joint Programme Neurodegenerative Diseases 2019-03401Family Rönström Foundation FRS-0003Family Rönström Foundation FRS-0004Knut and Alice Wallenberg Foundation 2022-0231NIA NIH HHS R01 AG083740NIA NIH HHS R01AG083740Skåne University Hospital Foundation 2020-O000028Skåne University Hospital Foundation 2022-1259Swedish Alzheimer Foundation AF-980907 AF-981132Swedish Alzheimer Foundation AF-994229Swedish Brain Foundation (Hjärnfonden) FO2021-0293Swedish Brain Foundation (Hjärnfonden) FO2022-0204Swedish Brain Foundation (Hjärnfonden) FO2023-0163Swedish Research Council 2021-02219Swedish Research Council 2022-00775 2018-02052WASP and DDLS Joint call for research projects WASP/DDLS22-066
6 · The paper itself

Abstract

introductionWe aimed to develop an algorithm to predict the individualized risk of future dementia using brief cognitive tests suitable for primary care.

methodsWe included 612 participants with subjective cognitive decline (SCD) or mild cognitive impairment (MCI) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study, assessed for at least 4 years or until progression to dementia. A logistic regression model, using cognitive tests as predictors and dementia progression as an outcome, stratified participants into low, intermediate, or high risk. A second model, including 1-year cognitive test changes, was applied to the intermediate group. The models were replicated in 392 SCD/MCI participants from the BioFINDER-1 study.

resultsThe best two-step model for predicting dementia incorporated Trail Making Test B (attention/executive function), Animal Fluency (verbal fluency), Mini-Mental State Examination (global cognition), and 10-word list recall (memory). The model's positive predictive value in ADNI was 85.8% and negative predictive value was 92.2% versus 62.5% and 95.6%, respectively, in BioFINDER-1. DISCUSSION: This two-step model accurately predicts individualized dementia risk. HIGHLIGHTS: To our knowledge, this is the first algorithm for predicting all-cause dementia using a novel two-step model utilizing brief cognitive tests. Applying a validated model including the Trail Making Test B, Animal Fluency, MMSE, Alzheimer's Disease Assessment Scale delayed, and immediate recall can robustly and accurately categorize individuals into low, intermediate, or high risk of dementia progression and can facilitate clinical decision-making and personalized patient care. We created an app that is available for research and educational purposes at https://brainapps.shinyapps.io/PredictAllCauseDementia to provide an individualized risk score for dementia progression.

Indexed as

Cognitive DysfunctionDementiaDisease ProgressionNeuropsychological TestsAgedAged, 80 and overAlgorithmsFemaleHumansMaleMental Status and Dementia TestsPredictive Value of Testscognitive impairmentdementiamild cognitive impairmentprediction dementiasubjective cognitive declinetwo‐step model

Identifiers

PMID39417379
PMCPMC11667515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.